Clinical Trials Browser

Phase 2 × Oxaliplatin × Genitourinary × Clear all

Parkinson Disease 4, Autosomal Dominant Lewy Body, Squamous Cell Carcinoma of Head and Neck, Urinary Bladder Neoplasms, Uterine Cervical Neoplasms, Esophageal Neoplasms, Gallbladder Neoplasms, Carcinoma, Hepatocellular, Ovarian Neoplasms, Stomach Neoplasms, Endometrial Neoplasms, Cholangiocarcinoma, Triple Negative Breast Neoplasms

NCT00627432 2025-02-18

Gemcitabine With Or Without Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Bladder Cancer

Phase 2 Completed

44 enrolled

Genitourinary

Urinary Bladder Neoplasms

NCT03451331 2024-05-16

Gemcitabine + Carboplatin + Nivolumab Versus Gemcitabine + Oxaliplatin + Nivolumab in Cisplatin-ineligible Patients With Metastatic Urothelial Cancer

Phase 2 Completed

49 enrolled 15 charts

Genitourinary

Metastatic Urothelial Cancer

NCT04049344 2019-08-08

Decitabine Combined With Oxaliplatin in Patients With Advanced Renal Cell Carcinoma

Phase 2 Unknown

25 enrolled

Genitourinary

Carcinoma, Renal Cell

NCT03159143 2017-08-11

Study of Docetaxel and Oxaliplatin in Metastatic Transitional Cell Cancer (TCC) of the Urothelial Tract

Phase 2 Completed

22 enrolled 8 charts

Genitourinary

Metastatic Transitional Cell Cancer of the Urothelial Tract

NCT00183820 2017-07-07

Study of Gemcitabine, Oxaliplatin, and Paclitaxel in Patients With Refractory Germ Cell Carcinoma

Phase 2 Completed

30 enrolled

Genitourinary

Neoplasms, Germ Cell and Embryonal, Testicular Neoplasms

NCT00957905 2017-03-10

Alvocidib and Oxaliplatin With or Without Fluorouracil and Leucovorin Calcium in Treating Patients With Relapsed or Refractory Germ Cell Tumors

Phase 2 Completed

36 enrolled 7 charts

Genitourinary

Testicular Neoplasms

NCT00260611 2015-03-25

Study of Oxaliplatin and Taxotere in Prostate Cancer

Phase 2 Completed

34 enrolled

Genitourinary

Prostatic Neoplasms

NCT00004203 2013-09-05

Oxaliplatin in Treating Patients With Metastatic Bladder Cancer

Phase 2 Completed

20 enrolled

Genitourinary

Urinary Bladder Neoplasms

NCT00091182 2013-06-05

Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment

Phase 2 Completed

180 enrolled

CNSEndocrineGastrointestinalGenitourinaryGynecologicHead & NeckSarcoma

Familial ependymoma, Ovarian Germ Cell Cancer, Astrocytoma, Carcinoma, Renal Cell, Colonic Neoplasms, Nasopharyngeal Neoplasms, Neuroblastoma, Rectal Neoplasms, Osteosarcoma, Teratoma, Testicular Neoplasms, Hepatoblastoma, Neuroectodermal Tumors, Primitive, Peripheral, Adrenocortical Carcinoma, Optic Nerve Glioma

NCT00186277 2011-03-30

Phase II Study of Oxaliplatin and Taxotere in Metastatic Bladder Cancer

Phase 2 Completed

10 enrolled

Genitourinary

Urinary Bladder Neoplasms

Clinical Trials

KEYVIBE-005

Gemcitabine With Or Without Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Bladder Cancer

Gemcitabine + Carboplatin + Nivolumab Versus Gemcitabine + Oxaliplatin + Nivolumab in Cisplatin-ineligible Patients With Metastatic Urothelial Cancer

Decitabine Combined With Oxaliplatin in Patients With Advanced Renal Cell Carcinoma

Study of Docetaxel and Oxaliplatin in Metastatic Transitional Cell Cancer (TCC) of the Urothelial Tract

Study of Gemcitabine, Oxaliplatin, and Paclitaxel in Patients With Refractory Germ Cell Carcinoma

Alvocidib and Oxaliplatin With or Without Fluorouracil and Leucovorin Calcium in Treating Patients With Relapsed or Refractory Germ Cell Tumors

Study of Oxaliplatin and Taxotere in Prostate Cancer

Oxaliplatin in Treating Patients With Metastatic Bladder Cancer

Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment

Phase II Study of Oxaliplatin and Taxotere in Metastatic Bladder Cancer